Emergent BioSolutions (Canada)
Emergent BioSolutions Inc. is an American multinational specialty biopharmaceutical company headquartered in Gaithersburg, Maryland. It develops vaccines and antibody therapeutics for infectious diseases and opioid overdoses, and it provides medical devices for biodefense purposes. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Emergent BioSolutions (Canada), Canada, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
64%
Total
Publications
141
Total Open
Publications
90
Total
Citations
2.3K
Open Access
Percentage
64%
Total
Publications
141
Total Open
Publications
90
Total
Citations
2.3K
Breakdown
Publisher Open
27%
Both
30%
Other Platform Open
5%
Closed
38%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 44%
34
Hybrid 18%
14
No Guarantees 38%
29
Other Platform Open
Domain 68%
32
Institution 21%
10
Other Internet 21%
10
Public 11%
5
Preprint 9%
4
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 32 |
DOI | Other Internet | 10 |
arXiv | Preprint | 5 |
Figshare | Public | 4 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 3 |
Ecole Polytechnique Fédérale de Lausanne - Infoscience | Institution | 3 |
Europe PMC | Domain | 2 |
Zenodo | Public | 1 |
Utah State University - Utah State Research and Scholarship | Institution | 1 |
University of Oslo - Duo Research Archive | Institution | 1 |